See what CeloNova is doing about COVID-19 Read More

Newsroom

News & Press Releases


COBRA PzF NanoCoated Coronary Stent Demonstrates Exceptional Long-Term Safety and Low ID-TLR at Five Years in Highly Complex Patients Undergoing PCI

San Antonio - May 13 2021

Positive results from the landmark PzF SHIELD IDE clinical trial reinforce safe and effective use in a real-world clinical practice of the world's first non-drug-eluting, nanocoated coronary stent.


Browse Our Archives